Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
14 July 2016
Header
Header image
From our blog

From our blog

Swedish Incentives Model Set to Launch Effective Fightback Against AMR
14 July 2016 by Brendan Barnes

2016 has been a good year in the battle against Anti-Microbial Resistance (AMR), considered by many to be one of the greatest health threats facing mankind. 

Read more

From our blog

#medsdisposal Scales New Heights to Success
14 July 2016 by #medsdisposal campaign partners

The #medsdisposal campaign is hitting new highs and breaking down barriers empowering people to dispose of their unwanted medicines safely and efficiently. It’s time to wax lyrical about waste.

Read more

Events calendar

Events Calendar

3rd EUCROF Conference - Flying to 2020: Managing Turbulences of Innovation and Change
From 17/10/2016 to 18/10/2016 (Prague)

The third EUCROF International Conference builds on the success of our previous Conferences in Brussels and Paris. It is the variety of topics related to clinical research that offers the attendees an exceptional opportunity to listen and learn about the "Quo vadis" of clinical research in Europe.

Read more

Events Calendar

Vaccines Today Communication Challenge 2016
From 18/07/2016 to 31/07/2016

Vaccines give us a world of possibilities. They're our passports to safe, healthy travel. So for this year's Vaccines Today Communication Challenge, we're asking for photos and stories of how vaccines have changed the way we live and travel. 

Read more

Events Calendar

Addressing the changing landscape for EU clinical trials
From 07/09/2016 to 09/09/2016 (Brussels)

With the advent of new European regulations, as well as the introduction of innovative research methods and technologies, the clinical trial landscape is fast evolving. 

EORTC will be hosting two events in September, addressing the topics of new EU regulations and new research methodologies in clinical trials:

Navigating Safely through the Regulatory Triangle: (Clinical Trials – In vitro Diagnostics – Data Protection) is a one-day course, which examines how the various elements of these regulations come together, and their potential impact on clinical research. It is targeted at: regulatory specialists in (bio)pharma; representatives of patient advocacy groups; and any other person with an interest in clinical trial regulations and drug development competitiveness in Europe.

Where: Brussels, Belgium – When: 7 September 2016

Innovation and Biomarkers in Cancer Drug Development (IBCD), a first-of-a-kind joint meeting by EORTC, NCI, EMA, and AACR explores the complexity of new cancer drug and biomarker development requirements. IBCD 2016 will help forge multi-stakeholder approaches to cancer drug development with new cancer biomarkers, with an extensive scientific programme that includes input from regulators, industry, academia, patients and payers.

Where: Brussels, Belgium – When: 8-9 September 2016

Read more

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

Documents

From our blog

The EU – US Transatlantic Trade and Investment Partnership (TTIP): Impact on EU economy, society and patients
14 July 2016 (Publications)

An ambitious pharmaceutical chapter in TTIP that aligns regulatory regimes and reduces duplicative costs will increase EU pharmaceutical exports by €9 billion and provide 19,000 [...] Read more

What we are reading

What we are reading

Focus on outcomes to meet health challenges
14 July 2016 (pharmaphorum Deep Dive)

EFPIA’s director general, Richard Bergström, says the industry is willing to partner with payers to deliver outcomes-driven, sustainable healthcare and overcome the challenges of rising demand from ageing populations and chronic diseases. But he also points to the fact that expenditure on drugs in Europe is falling and accounts for less than 20% of the total healthcare spend.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail